RxSight, Inc. RXST
4.66
(0.07)
(1.48%)
as of 25 Sep
- Market cap
- $196.7M
- P/E
- 0.0×
Follow RXST
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 4.31 | 4.31 | 6.78 | 7.21 | 14.18 | 9.55 | 3.17 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (5.48) | (5.48) | (17.57) | (25.52) | (152.12) | (313.68) | (381.42) |
P/B ratio |
— | 0.00 | 0.00 | 1.11 | 3.93 | 7.87 | 4.75 | 1.54 |
Price to Tangible BV |
— | 0.00 | 0.00 | 1.11 | 3.93 | 7.87 | 4.75 | 1.54 |
EV/Sales |
— | 2.85 | 2.85 | 1.49 | 5.87 | 12.76 | 7.86 | 1.48 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (1.16) | (1.16) | (0.75) | (4.89) | (27.34) | (64.94) | (12.82) |
EV/FCF |
— | (1.09) | (1.09) | (0.72) | (4.70) | (24.50) | (49.16) | (10.28) |
Quick Ratio |
— | 9.63 | 6.19 | 14.82 | 6.77 | 7.05 | 10.33 | 9.58 |
Current Ratio |
— | 10.67 | 7.03 | 15.92 | 7.81 | 8.06 | 11.36 | 10.95 |
Net Debt/EBITDA |
— | 1.76 | 1.40 | 2.47 | 1.09 | 2.45 | 5.61 | 4.27 |
Debt/Assets |
0.00% | 4.99% | 24.23% | 20.63% | 26.75% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.24 | 9.08 | 0.29 | 0.45 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.04 | 0.14 | 0.15 | 0.29 | 0.54 | 0.56 | 0.43 |
Operating CF/Net income |
— | (1.55) | (10.46) | 0.92 | 0.88 | 0.86 | 0.62 | 0.40 |
Capex/Depreciation |
— | 0.00 | (0.69) | (0.44) | (0.76) | 2.74 | 1.01 | 0.73 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | (1.03%) | 45.85% | (58.52%) | (38.85%) | (12.43%) | (13.99%) | |
| — | 47.32% | 3.19% | (33.19%) | (38.94%) | (29.22%) | (10.96%) | (12.36%) | |
ROIC |
— | 0.00% | 0.00% | (176.71%) | (163.06%) | (94.34%) | (52.34%) | (63.34%) |
Return on Tangible Assets |
— | 25.87% | 4.05% | (27.60%) | (52.38%) | (30.70%) | (9.79%) | (14.20%) |
Average Days of Receivables |
— | 128.51 | 71.24 | 78.55 | 81.60 | 83.10 | 78.39 | 63.47 |
Research and Development Expense of Revenue |
— | 1,319.46% | 149.43% | 108.44% | 53.02% | 32.61% | 24.56% | 28.67% |
Selling, General and Administrative Expense of Revenue |
— | 678.40% | 103.39% | 145.20% | 119.71% | 83.97% | 72.49% | 83.77% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 28.51% | 33.53% | 23.26% | 17.68% | 17.61% | 23.51% |
Graham Net Nets |
— | 0.31 | 0.31 | 0.79 | 0.21 | 0.12 | 0.19 | 0.59 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (55.49%) | (55.49%) | (55.49%) | (18.94%) | (3.90%) | (2.09%) | (9.12%) |
Free Cash Flow Yield |
— | (60.68%) | (60.68%) | (30.43%) | (17.32%) | (3.67%) | (1.68%) | (4.54%) |
Revenue per Share |
— | 0.08 | 3.96 | 1.66 | 1.77 | 2.59 | 3.60 | 3.29 |
Operating CF per Share |
— | (1.47) | (9.50) | (3.28) | (2.13) | (1.21) | (0.44) | (0.38) |
Capex per Share |
— | 0.00 | (0.68) | (0.14) | (0.09) | (0.14) | (0.14) | (0.09) |
Free Cash Flow per Share |
— | (1.47) | (10.18) | (3.42) | (2.21) | (1.35) | (0.58) | (0.47) |
Cash per Share |
— | 2.92 | 18.61 | 11.69 | 3.82 | 3.69 | 6.10 | 5.58 |
Shareholders Equity per Share |
— | 0.83 | 0.72 | 10.15 | 3.25 | 4.65 | 7.24 | 6.75 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.83 | 0.72 | 10.15 | 3.25 | 4.65 | 7.24 | 6.75 |
Free Cash Flow |
— | (40.62) | (37.74) | (46.65) | (61.24) | (46.41) | (22.39) | (19.34) |
Working Capital |
— | 81.74 | 69.90 | 165.22 | 117.32 | 147.50 | 267.95 | 261.21 |
Capital Expenditures |
— | (4.09) | (2.54) | (1.94) | (2.39) | (4.81) | (5.44) | (3.83) |
Net Current Asset Value |
— | 2.74 | (16.49) | 121.82 | 74.29 | 146.22 | 256.50 | 251.33 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.17 | 0.09 | 0.05 | 0.05 | 0.04 | 0.03 |
Net Profit Margin |
— | 1,165.86% | 22.93% | (215.50%) | (136.22%) | (54.57%) | (19.62%) | (28.96%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.20 | 0.27 | 0.40 | 0.31 | (0.16) | (0.44) | (0.40) |
Cash ROIC |
— | (54.85%) | (50.48%) | (16.58%) | (29.25%) | (18.24%) | (5.66%) | (5.67%) |
Accounts Receivable Turnover |
— | 0.00 | 8.03 | 5.85 | 6.20 | 5.70 | 5.56 | 5.03 |
Accounts Payable Turnover |
— | 0.00 | 7.78 | 12.81 | 12.92 | 10.94 | 9.75 | 6.40 |
Inventory Turnover |
— | 0.00 | 1.67 | 2.22 | 2.42 | 2.19 | 2.08 | 1.18 |
Average Days of Payables |
— | 197.69 | 31.91 | 34.11 | 34.22 | 39.93 | 40.47 | 61.42 |
Days of Inventory on Hand |
— | 649.00 | 233.19 | 162.19 | 195.64 | 180.07 | 196.01 | 366.03 |
Average Receivables |
— | — | 1.83 | 3.86 | 7.91 | 15.62 | 25.17 | 26.72 |
Average Payables |
— | — | 1.67 | 1.41 | 2.14 | 3.23 | 4.20 | 4.92 |
Average Inventory |
— | — | 7.75 | 8.16 | 11.43 | 16.13 | 19.72 | 26.78 |
Average Assets |
— | 55.22 | 105.55 | 146.70 | 171.44 | 166.36 | 250.56 | 315.19 |
Average Common Equity |
— | — | (327.61) | (106.19) | 114.07 | 125.13 | 220.80 | 278.46 |
Columns are period end dates